Thiel KW, Devor EJ, Filiaci VL, Mutch D, et al. TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study. J Clin Oncol 2022;40:3289-3300.
PMID: 35658479